{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:15:27Z","timestamp":1783440927084,"version":"3.54.6"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"UKHSA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ceftriaxone resistance threatens the last remaining empirical monotherapy for Neisseria gonorrhoeae. Ceftriaxone-resistant N. gonorrhoeae is rare in England, but cases are increasing. Rapid detection of ceftriaxone resistance, commonly conferred by mutations in the penA gene, facilitates rapid risk assessment and public health intervention including enhanced follow-up of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to develop a real-time PCR for detection of the ceftriaxone resistance-associated penA-237.001 allele in N. gonorrhoeae, for use on both cultured isolates and residual clinical specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A penA-237.001-specific assay was designed and evaluated using cultured isolates, residual clinical specimens and a broad exclusivity panel. Analytical sensitivity was assessed using serial dilutions of two penA-237.001-positive isolates prepared in specimen collection kit buffers and PBS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The assay demonstrated 100% specificity within the validation panel; all penA-237.001-positive isolates were correctly identified with no false-positive results. Detection was reliable to approximately 15\u2005cfu\/mL across all buffer types, with minimal cycle threshold variation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This assay enables rapid and specific detection of penA-237.001 in cultured isolates and residual molecular specimens. Used alongside existing molecular assays, it offers enhanced early detection of ceftriaxone-resistant N. gonorrhoeae and supports timely public health action.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag211","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:18:52Z","timestamp":1783437532000},"source":"Crossref","is-referenced-by-count":0,"title":["Improved molecular detection of ceftriaxone resistance in\n                    <i>Neisseria gonorrhoeae<\/i>\n                    in a reference laboratory setting"],"prefix":"10.1093","volume":"81","author":[{"given":"Anna","family":"Vickers","sequence":"first","affiliation":[{"name":"STI Reference Laboratory, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Day","sequence":"additional","affiliation":[{"name":"STI Reference Laboratory, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Doumith","sequence":"additional","affiliation":[{"name":"Formerly at UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Vivekanand","sequence":"additional","affiliation":[{"name":"STI Reference Laboratory, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-6039","authenticated-orcid":false,"given":"Penelope R","family":"Cliff","sequence":"additional","affiliation":[{"name":"STI Reference Laboratory, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7756-403X","authenticated-orcid":false,"given":"Helen","family":"Fifer","sequence":"additional","affiliation":[{"name":"Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9086-9222","authenticated-orcid":false,"given":"Sarah","family":"Alexander","sequence":"additional","affiliation":[{"name":"STI Reference Laboratory, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pitt-Kendall","sequence":"additional","affiliation":[{"name":"STI Reference Laboratory, UK Health Security Agency , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2026070711183473700_dkag211-B1","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/jac\/dkae369","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis","volume":"79","author":"Fifer","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026070711183473700_dkag211-B2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.15585\/mmwr.mm7312a2","article-title":"Ceftriaxone-resistant gonorrhea\u2014China, 2022","volume":"73","author":"Zhu","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026070711183473700_dkag211-B3","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae053","article-title":"High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022-23: WHO enhanced gonococcal antimicrobial surveillance programme (EGASP)","volume":"6","author":"Ouk","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026070711183473700_dkag211-B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101125","article-title":"The WHO enhanced gonococcal antimicrobial surveillance programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023","volume":"48","author":"Lan","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026070711183473700_dkag211-B5","author":"UK Health Security Agency"},{"key":"2026070711183473700_dkag211-B6","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1177\/09564624251345195","article-title":"British Association of Sexual Health and HIV UK national guideline for the management of infection with Neisseria gonorrhoeae, 2025","volume":"36","author":"Fifer","year":"2025","journal-title":"Int J STD AIDS"},{"key":"2026070711183473700_dkag211-B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jgar.2019.02.011","article-title":"A real-time PCR assay for detecting a penA mutation associated with ceftriaxone resistance in Neisseria gonorrhoeae","volume":"19","author":"Shimuta","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"2026070711183473700_dkag211-B8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/sextrans-2024-056132","article-title":"Molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae clinical specimens: a tool for public health control","volume":"100","author":"Day","year":"2024","journal-title":"Sex Transm Infect"},{"key":"2026070711183473700_dkag211-B9","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1093\/cid\/ciaf530","article-title":"penA alleles associated with gonococcal ceftriaxone resistance in Cambodia, China, and Vietnam","volume":"81","author":"van der Veen","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026070711183473700_dkag211-B10","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200899","article-title":"Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022","volume":"27","author":"Bercot","year":"2022","journal-title":"Euro Surveill"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/8\/dkag211\/68708705\/dkag211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/8\/dkag211\/68708705\/dkag211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:18:53Z","timestamp":1783437533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag211\/8726230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag211","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"dkag211"}}